Use of Teriparatide injections for osteoporosis at a teaching hospital in Japan. Pharmacy-led New Medicine Use Evaluation (MUE) programme.

• In: Posters
• At: Dublin (Ireland) (2013)
• Type: Poster
• By: UEDA, Aya (St Marianna University Hospital, Pharmacy, Kawasaki, Japan)
• Co-author(s): Akazawa, M. (Meiji Pharmaceutical University, Tokyo, Kiyose, Japan)
  Masuhara, K. (St Marianna University Hospital, Kawasaki, Japan)
  Sugimura, H. (St Marianna University Hospital, Kawasaki, Japan)
  Okamoto, S. (St Marianna University Hospital, Kawasaki, Japan)
  Oshige, M. (St Marianna University Hospital, Kawasaki, Japan)
  Yoshida, J. (St Marianna University Hospital, Kawasaki, Japan)
  Dhillon, S. (University of Hertfordshire, Hatfield, United Kingdom)
  
• Abstract:

  Background
  Entry of new drugs to a hospital formulary has been assessed at a local level in Japan. We initiated a pharmacy-led new medicine use evaluation (MUE) programme for selected high risk/cost drugs to ensure that these medicines were appropriately used.
  Aims
  A case study of teriparatide, a new high cost agent to treat osteoporosis, is reported.
  

  ..

The access to the whole abstract and if available the presentation file is available to FIP members and to congress participants of that specific congress. Please login